Drug-drug interactions and their predictors: Results from Indian elderly inpatients

Pharmacy Practice

Volumn 11, Issue 4, 2013, Pages 191-195

  Kashyap, Mandavi ^a   D'Cruz, Sanjay ^b   Sachdev, Atul ^b   Tiwari, Pramil ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^c NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Drug interactions; India; Inpatients

Indexed keywords

ACETYLSALICYLIC ACID; ALPRAZOLAM; AMOXICILLIN; ANTICOAGULANT AGENT; ATORVASTATIN; CARVEDILOL; CIPROFLOXACIN; CLOPIDOGREL; DIGOXIN; DILTIAZEM; FUROSEMIDE; HEPARIN; HYDROCHLOROTHIAZIDE; INSULIN; ISONIAZID; METOPROLOL; METRONIDAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RAMIPRIL; RIFAMPICIN; SPIRONOLACTONE; THEOPHYLLINE; WARFARIN;

ADULT; AGED; ARTICLE; COMORBIDITY; DRUG DRUG INTERACTION; FEMALE; HUMAN; ICD-10; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHARMACODYNAMICS; PRESCRIPTION; PREVALENCE; TEACHING HOSPITAL; VERY ELDERLY;

EID: 84890965138     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552013000400003     Document Type: Article

References (23)

1. Kevin K, He W. U.S. Census Bureau, International Population Reports. P95/09-1. An Aging World: 2008. Washington, DC: U.S. Government Printing Office; 2009.
2. Mendes-Netto RS, Silva CQV, Oliveira Filho A, Rocha CE, Lyra DP Jr. Assessment of Drug Interactions in elderly patients of a family health care unit in Aracaju (Brazil): A pilot study. Afr J Pharm Pharmacol 2011;5(7):812-818.
3. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289(13):1652-1658.
4. International classification of disease, in: International Statistical Classification of Diseases and Related Health Problems 10th Revision. 2007 version.
5. WHO collaborating centre for drug statistic methodology. Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Dose. Geneva: WHO; 2003.
6. DRUG-REAX (Micromedex), version 2010: Thomson MICROMEDEX; Greenwood Village, Colorado.
7. Stockley IH editor. Stockley's Drug Interactions. 7th edition. London: Pharmaceutical Press; 2006.
8. Roughead EE, Kalisch LM, Barratt JD, Gilbert AL. Prevalence of potentially hazardous drug interactions amongst Australian veterans. Br J Clin Pharmacol. 2010;70(2):252-257. doi: 10.1111/j.1365-2125.2010.03694.x
9. Braga TB, Pfaffenbach G, Weiss DP, Barros MB, Bergsten-Mendes G. Point prevalence of drug prescriptions for elderly and non-elderly inpatients in a teaching hospital. Sao Paulo Med J. 2004;122(2):48-52.
10. Locatelli J. Drug interactions in hospitalized elderly patients. Einstein 2007;5(4):343-346.
11. Bista D, Saha A, Mishra P, Palaian S, Shankar PR. Impact of educational intervention on the pattern and incidence of potential drug-drug interactions in Nepal. Pharm Pract (Granada). 2009;7(4):242-247.
12. Manchon ND, Bercoff E, Lemarchand P, Chassagne P, Senant J, Bourreille J. Incidence and severity of drug interactions in the elderly: a prospective study of 639 patients. Rev Med Interne. 1989;10(6):521-525.
13. Doubova SV, Reyes-Morales H, Torres-Arreola LP, Suárez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res. 2007;7:147.
14. Robert-Ebadi H, Le Gal G, Righini M. Use of anticoagulants in elderly patients: practical recommendations. Clin Interv Aging. 2009;4:165-177.
15. Bajorek B. A review of the safety of anticoagulants in older people using the medicines management pathway. Ther Adv Drug Saf. 2011;2(2):45-58.
16. Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, Kopp A, Mamdani MM. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180(7):713-718. doi:10.1503/cmaj.082001
17. Lau WC, Gurbel PA. The drug-drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180(7):699-700. doi: 10.1503/cmaj.090251
18. Allen MJ, McLean-Veysey P. Interaction between clopidogrel and proton pump inhibitors. CMAJ. 2009;180(12):1228-1229.
19. Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J. 2009;157(1):148. e1-e5. doi: 10.1016/j.ahj.2008.09.017
20. Sibbing D, Morath T, Stegherr J, Braun S, Vogt W, Hadamitzky M, Schömig A, Kastrati A, von Beckerath N. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb Haemost. 2009;101(4):714-719.
21. Small DS, Farid NA, Payne CD, Weerakkody GJ, Li YG, Brandt JT, Salazar DE, Winters KJ. Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J Clin Pharmacol. 2008;48(4):475-484. doi: 10.1177/0091270008315310
22. Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP; COGENT Investigators. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010;363(20):1909-1917. doi: 10.1056/NEJMoa1007964
23. Momary K, Cavallari LH. Clopidogrel and proton pump inhibitors: between a rock and a hard place. Pharmacotherapy. 2010;30(8):762-765. doi: 10.1592/phco.30.8.762